Clinical Trials Overview
We are devoted to discovering and developing medicines that improve the lives of patients with the most difficult-to-treat diseases. As part of that process, we must conduct clinical trials to establish their efficacy, safety and tolerability to gain approval from regulatory agencies in the United States and around the world.
Patient participation in clinical trials is important. If you are chosen to enroll in one of our trials, you will be participating in important health research and helping to advance the scientific understanding of cancer.
Read more to see where our clinical trial sites are located and the types of diseases for which we are evaluating our investigational medicines.
Find Clinical Trials Near Me
|Study Phase||Disease Type(s)||Investigational Medicine||Status|
|Phase 1||COVID-19||CPI-006 + Standard of care||Completed||More Info|
|Phase 1/1b||Multiple solid tumors||
|Phase 1/1b||T-Cell Lymphomas||CPI-818||Recruiting||More Info|
|Phase 1/1b||Renal cell carcinoma (RCC)||Ciforadenant + atezolizumab||Completed||More Info|
For more information on our product candidates, please see our Annual Report available in the SEC Filings section of the website.
We are developing immunology focused medicines that target the most critical cellular elements of the immune system
Who We Are
We are committed to developing better medicines to improve the lives of people with cancer, immune disorders and infectious diseases